- Home
- IPI vs CRDF Comparison
IPI vs CRDF Comparison
Compare IPI & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPI
- CRDF
- Stock Information
- Founded
- IPI 2000
- CRDF 1999
- Country
- IPI United States
- CRDF United States
- Employees
- IPI N/A
- CRDF N/A
- Industry
- IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IPI Industrials
- CRDF Health Care
- Exchange
- IPI Nasdaq
- CRDF Nasdaq
- Market Cap
- IPI 288.5M
- CRDF 240.2M
- IPO Year
- IPI 2008
- CRDF N/A
- Fundamental
- Price
- IPI $27.18
- CRDF $3.52
- Analyst Decision
- IPI Sell
- CRDF Strong Buy
- Analyst Count
- IPI 2
- CRDF 3
- Target Price
- IPI $21.00
- CRDF $10.33
- AVG Volume (30 Days)
- IPI 121.4K
- CRDF 1.2M
- Earning Date
- IPI 03-05-2025
- CRDF 02-27-2025
- Dividend Yield
- IPI N/A
- CRDF N/A
- EPS Growth
- IPI N/A
- CRDF N/A
- EPS
- IPI N/A
- CRDF N/A
- Revenue
- IPI $206,359,000.00
- CRDF $688,000.00
- Revenue This Year
- IPI N/A
- CRDF $25.03
- Revenue Next Year
- IPI $3.40
- CRDF N/A
- P/E Ratio
- IPI N/A
- CRDF N/A
- Revenue Growth
- IPI N/A
- CRDF 49.57
- 52 Week Low
- IPI $17.52
- CRDF $1.44
- 52 Week High
- IPI $29.75
- CRDF $6.42
- Technical
- Relative Strength Index (RSI)
- IPI 65.09
- CRDF 46.40
- Support Level
- IPI $26.23
- CRDF $3.33
- Resistance Level
- IPI $27.79
- CRDF $4.89
- Average True Range (ATR)
- IPI 1.12
- CRDF 0.29
- MACD
- IPI 0.64
- CRDF -0.13
- Stochastic Oscillator
- IPI 91.13
- CRDF 14.91
About IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").